BEXTRA Trademark

Trademark Overview

On Sunday, December 24, 2017, a trademark application was filed for BEXTRA with the United States Patent and Trademark Office. The USPTO has given the BEXTRA trademark a serial number of 87733446. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 11, 2021. This trademark is owned by Tremeau Pharmaceuticals, Inc.. The BEXTRA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of pain, inflammation and arthritis
bextra

General Information

Serial Number87733446
Word MarkBEXTRA
Filing DateSunday, December 24, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 11, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 10, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of pain, inflammation and arthritis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 11, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTremeau Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressConcord, MA 01742
Party NameTremeau Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Monday, January 11, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 11, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 9, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 5, 2020EXTENSION 4 GRANTED
Friday, June 5, 2020EXTENSION 4 FILED
Friday, June 5, 2020TEAS EXTENSION RECEIVED
Friday, December 6, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 4, 2019EXTENSION 3 GRANTED
Wednesday, December 4, 2019EXTENSION 3 FILED
Wednesday, December 4, 2019TEAS EXTENSION RECEIVED
Friday, June 7, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 5, 2019EXTENSION 2 GRANTED
Wednesday, June 5, 2019EXTENSION 2 FILED
Wednesday, June 5, 2019TEAS EXTENSION RECEIVED
Thursday, November 22, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 20, 2018EXTENSION 1 GRANTED
Tuesday, November 20, 2018EXTENSION 1 FILED
Tuesday, November 20, 2018TEAS EXTENSION RECEIVED
Wednesday, October 17, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, October 17, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 5, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 10, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 10, 2018PUBLISHED FOR OPPOSITION
Wednesday, March 21, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, March 8, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 6, 2018ASSIGNED TO EXAMINER
Thursday, January 11, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Wednesday, December 27, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

bextra inflammation arthritis pain treatment preparations pharmaceutical